 | • レポートコード：GIR-23F3786 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Drug for Ulcerative Colitis Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の潰瘍性大腸炎治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 潰瘍性大腸炎治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・経口型、注射型 アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア 世界の潰瘍性大腸炎治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Johnson & Johnson.、AbbVie、Takeda Pharmaceuticals、Roche、Warner Chilcott、Salix Pharmaceuticals/Santarus、Takeda、Ferring Pharmaceuticals、Pfizer、InDeX Pharmaceuticals 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 潰瘍性大腸炎治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：経口型、注射型 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア - 世界の潰瘍性大腸炎治療薬市場規模・予測 - 世界の潰瘍性大腸炎治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Johnson & Johnson.、AbbVie、Takeda Pharmaceuticals、Roche、Warner Chilcott、Salix Pharmaceuticals/Santarus、Takeda、Ferring Pharmaceuticals、Pfizer、InDeX Pharmaceuticals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：経口型、注射型 ・アプリケーション別分析2017年-2028年：病院、ドラッグストア ・潰瘍性大腸炎治療薬の北米市場分析 - 潰瘍性大腸炎治療薬の北米市場：タイプ別市場規模2017年-2028年 - 潰瘍性大腸炎治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・潰瘍性大腸炎治療薬のヨーロッパ市場分析 - ：潰瘍性大腸炎治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：潰瘍性大腸炎治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・潰瘍性大腸炎治療薬のアジア太平洋市場分析 - 潰瘍性大腸炎治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 潰瘍性大腸炎治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・潰瘍性大腸炎治療薬の南米市場分析 - 潰瘍性大腸炎治療薬の南米市場：タイプ別市場規模2017年-2028年 - 潰瘍性大腸炎治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・潰瘍性大腸炎治療薬の中東・アフリカ市場分析 - 潰瘍性大腸炎治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 潰瘍性大腸炎治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drug for Ulcerative Colitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug for Ulcerative Colitis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Drug for Ulcerative Colitis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug for Ulcerative Colitis include Johnson & Johnson., AbbVie, Takeda Pharmaceuticals, Roche, and Warner Chilcott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug for Ulcerative Colitis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital
Drugs Stores
The key market players for global Drug for Ulcerative Colitis market are listed below:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Takeda
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug for Ulcerative Colitis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug for Ulcerative Colitis, with price, sales, revenue and global market share of Drug for Ulcerative Colitis from 2019 to 2022.
Chapter 3, the Drug for Ulcerative Colitis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug for Ulcerative Colitis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug for Ulcerative Colitis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug for Ulcerative Colitis.
Chapter 13, 14, and 15, to describe Drug for Ulcerative Colitis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drug for Ulcerative Colitis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug for Ulcerative Colitis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug for Ulcerative Colitis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Drug for Ulcerative Colitis Market Size & Forecast
1.4.1 Global Drug for Ulcerative Colitis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug for Ulcerative Colitis Sales in Volume (2017-2028)
1.4.3 Global Drug for Ulcerative Colitis Price (2017-2028)
1.5 Global Drug for Ulcerative Colitis Production Capacity Analysis
1.5.1 Global Drug for Ulcerative Colitis Total Production Capacity (2017-2028)
1.5.2 Global Drug for Ulcerative Colitis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug for Ulcerative Colitis Market Drivers
1.6.2 Drug for Ulcerative Colitis Market Restraints
1.6.3 Drug for Ulcerative Colitis Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson.
2.1.1 Johnson & Johnson. Details
2.1.2 Johnson & Johnson. Major Business
2.1.3 Johnson & Johnson. Drug for Ulcerative Colitis Product and Services
2.1.4 Johnson & Johnson. Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Drug for Ulcerative Colitis Product and Services
2.2.4 AbbVie Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda Pharmaceuticals
2.3.1 Takeda Pharmaceuticals Details
2.3.2 Takeda Pharmaceuticals Major Business
2.3.3 Takeda Pharmaceuticals Drug for Ulcerative Colitis Product and Services
2.3.4 Takeda Pharmaceuticals Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Drug for Ulcerative Colitis Product and Services
2.4.4 Roche Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Warner Chilcott
2.5.1 Warner Chilcott Details
2.5.2 Warner Chilcott Major Business
2.5.3 Warner Chilcott Drug for Ulcerative Colitis Product and Services
2.5.4 Warner Chilcott Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Salix Pharmaceuticals/Santarus
2.6.1 Salix Pharmaceuticals/Santarus Details
2.6.2 Salix Pharmaceuticals/Santarus Major Business
2.6.3 Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Product and Services
2.6.4 Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Drug for Ulcerative Colitis Product and Services
2.7.4 Takeda Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ferring Pharmaceuticals
2.8.1 Ferring Pharmaceuticals Details
2.8.2 Ferring Pharmaceuticals Major Business
2.8.3 Ferring Pharmaceuticals Drug for Ulcerative Colitis Product and Services
2.8.4 Ferring Pharmaceuticals Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Drug for Ulcerative Colitis Product and Services
2.9.4 Pfizer Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 InDeX Pharmaceuticals
2.10.1 InDeX Pharmaceuticals Details
2.10.2 InDeX Pharmaceuticals Major Business
2.10.3 InDeX Pharmaceuticals Drug for Ulcerative Colitis Product and Services
2.10.4 InDeX Pharmaceuticals Drug for Ulcerative Colitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug for Ulcerative Colitis Breakdown Data by Manufacturer
3.1 Global Drug for Ulcerative Colitis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug for Ulcerative Colitis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug for Ulcerative Colitis
3.4 Market Concentration Rate
3.4.1 Top 3 Drug for Ulcerative Colitis Manufacturer Market Share in 2021
3.4.2 Top 6 Drug for Ulcerative Colitis Manufacturer Market Share in 2021
3.5 Global Drug for Ulcerative Colitis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug for Ulcerative Colitis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug for Ulcerative Colitis Market Size by Region
4.1.1 Global Drug for Ulcerative Colitis Sales in Volume by Region (2017-2028)
4.1.2 Global Drug for Ulcerative Colitis Revenue by Region (2017-2028)
4.2 North America Drug for Ulcerative Colitis Revenue (2017-2028)
4.3 Europe Drug for Ulcerative Colitis Revenue (2017-2028)
4.4 Asia-Pacific Drug for Ulcerative Colitis Revenue (2017-2028)
4.5 South America Drug for Ulcerative Colitis Revenue (2017-2028)
4.6 Middle East and Africa Drug for Ulcerative Colitis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drug for Ulcerative Colitis Sales in Volume by Type (2017-2028)
5.2 Global Drug for Ulcerative Colitis Revenue by Type (2017-2028)
5.3 Global Drug for Ulcerative Colitis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drug for Ulcerative Colitis Sales in Volume by Application (2017-2028)
6.2 Global Drug for Ulcerative Colitis Revenue by Application (2017-2028)
6.3 Global Drug for Ulcerative Colitis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drug for Ulcerative Colitis Sales by Type (2017-2028)
7.2 North America Drug for Ulcerative Colitis Sales by Application (2017-2028)
7.3 North America Drug for Ulcerative Colitis Market Size by Country
7.3.1 North America Drug for Ulcerative Colitis Sales in Volume by Country (2017-2028)
7.3.2 North America Drug for Ulcerative Colitis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug for Ulcerative Colitis Sales by Type (2017-2028)
8.2 Europe Drug for Ulcerative Colitis Sales by Application (2017-2028)
8.3 Europe Drug for Ulcerative Colitis Market Size by Country
8.3.1 Europe Drug for Ulcerative Colitis Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug for Ulcerative Colitis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug for Ulcerative Colitis Sales by Type (2017-2028)
9.2 Asia-Pacific Drug for Ulcerative Colitis Sales by Application (2017-2028)
9.3 Asia-Pacific Drug for Ulcerative Colitis Market Size by Region
9.3.1 Asia-Pacific Drug for Ulcerative Colitis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug for Ulcerative Colitis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drug for Ulcerative Colitis Sales by Type (2017-2028)
10.2 South America Drug for Ulcerative Colitis Sales by Application (2017-2028)
10.3 South America Drug for Ulcerative Colitis Market Size by Country
10.3.1 South America Drug for Ulcerative Colitis Sales in Volume by Country (2017-2028)
10.3.2 South America Drug for Ulcerative Colitis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug for Ulcerative Colitis Sales by Type (2017-2028)
11.2 Middle East & Africa Drug for Ulcerative Colitis Sales by Application (2017-2028)
11.3 Middle East & Africa Drug for Ulcerative Colitis Market Size by Country
11.3.1 Middle East & Africa Drug for Ulcerative Colitis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug for Ulcerative Colitis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug for Ulcerative Colitis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug for Ulcerative Colitis
12.3 Drug for Ulcerative Colitis Production Process
12.4 Drug for Ulcerative Colitis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug for Ulcerative Colitis Typical Distributors
13.3 Drug for Ulcerative Colitis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Drug for Ulcerative Colitis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug for Ulcerative Colitis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson. Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson. Major Business
Table 5. Johnson & Johnson. Drug for Ulcerative Colitis Product and Services
Table 6. Johnson & Johnson. Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Major Business
Table 9. AbbVie Drug for Ulcerative Colitis Product and Services
Table 10. AbbVie Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Pharmaceuticals Major Business
Table 13. Takeda Pharmaceuticals Drug for Ulcerative Colitis Product and Services
Table 14. Takeda Pharmaceuticals Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Drug for Ulcerative Colitis Product and Services
Table 18. Roche Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Warner Chilcott Basic Information, Manufacturing Base and Competitors
Table 20. Warner Chilcott Major Business
Table 21. Warner Chilcott Drug for Ulcerative Colitis Product and Services
Table 22. Warner Chilcott Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Salix Pharmaceuticals/Santarus Basic Information, Manufacturing Base and Competitors
Table 24. Salix Pharmaceuticals/Santarus Major Business
Table 25. Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Product and Services
Table 26. Salix Pharmaceuticals/Santarus Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Takeda Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Major Business
Table 29. Takeda Drug for Ulcerative Colitis Product and Services
Table 30. Takeda Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Ferring Pharmaceuticals Major Business
Table 33. Ferring Pharmaceuticals Drug for Ulcerative Colitis Product and Services
Table 34. Ferring Pharmaceuticals Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Drug for Ulcerative Colitis Product and Services
Table 38. Pfizer Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. InDeX Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. InDeX Pharmaceuticals Major Business
Table 41. InDeX Pharmaceuticals Drug for Ulcerative Colitis Product and Services
Table 42. InDeX Pharmaceuticals Drug for Ulcerative Colitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drug for Ulcerative Colitis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drug for Ulcerative Colitis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drug for Ulcerative Colitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drug for Ulcerative Colitis Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drug for Ulcerative Colitis Production Site of Key Manufacturer
Table 48. Drug for Ulcerative Colitis New Entrant and Capacity Expansion Plans
Table 49. Drug for Ulcerative Colitis Mergers & Acquisitions in the Past Five Years
Table 50. Global Drug for Ulcerative Colitis Sales by Region (2017-2022) & (K Units)
Table 51. Global Drug for Ulcerative Colitis Sales by Region (2023-2028) & (K Units)
Table 52. Global Drug for Ulcerative Colitis Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drug for Ulcerative Colitis Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 55. Global Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 56. Global Drug for Ulcerative Colitis Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drug for Ulcerative Colitis Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drug for Ulcerative Colitis Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Drug for Ulcerative Colitis Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 61. Global Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 62. Global Drug for Ulcerative Colitis Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drug for Ulcerative Colitis Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drug for Ulcerative Colitis Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Drug for Ulcerative Colitis Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Drug for Ulcerative Colitis Sales by Country (2017-2022) & (K Units)
Table 67. North America Drug for Ulcerative Colitis Sales by Country (2023-2028) & (K Units)
Table 68. North America Drug for Ulcerative Colitis Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drug for Ulcerative Colitis Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 71. North America Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 72. North America Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 73. North America Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drug for Ulcerative Colitis Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drug for Ulcerative Colitis Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drug for Ulcerative Colitis Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drug for Ulcerative Colitis Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drug for Ulcerative Colitis Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drug for Ulcerative Colitis Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drug for Ulcerative Colitis Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drug for Ulcerative Colitis Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 90. South America Drug for Ulcerative Colitis Sales by Country (2017-2022) & (K Units)
Table 91. South America Drug for Ulcerative Colitis Sales by Country (2023-2028) & (K Units)
Table 92. South America Drug for Ulcerative Colitis Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drug for Ulcerative Colitis Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 95. South America Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 96. South America Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 97. South America Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drug for Ulcerative Colitis Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drug for Ulcerative Colitis Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drug for Ulcerative Colitis Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drug for Ulcerative Colitis Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drug for Ulcerative Colitis Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drug for Ulcerative Colitis Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drug for Ulcerative Colitis Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drug for Ulcerative Colitis Sales by Application (2023-2028) & (K Units)
Table 106. Drug for Ulcerative Colitis Raw Material
Table 107. Key Manufacturers of Drug for Ulcerative Colitis Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drug for Ulcerative Colitis Typical Distributors
Table 111. Drug for Ulcerative Colitis Typical Customers
List of Figures
Figure 1. Drug for Ulcerative Colitis Picture
Figure 2. Global Drug for Ulcerative Colitis Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Drug for Ulcerative Colitis Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drugs Stores
Figure 8. Global Drug for Ulcerative Colitis Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Drug for Ulcerative Colitis Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drug for Ulcerative Colitis Sales (2017-2028) & (K Units)
Figure 11. Global Drug for Ulcerative Colitis Price (2017-2028) & (USD/Unit)
Figure 12. Global Drug for Ulcerative Colitis Production Capacity (2017-2028) & (K Units)
Figure 13. Global Drug for Ulcerative Colitis Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drug for Ulcerative Colitis Market Drivers
Figure 15. Drug for Ulcerative Colitis Market Restraints
Figure 16. Drug for Ulcerative Colitis Market Trends
Figure 17. Global Drug for Ulcerative Colitis Sales Market Share by Manufacturer in 2021
Figure 18. Global Drug for Ulcerative Colitis Revenue Market Share by Manufacturer in 2021
Figure 19. Drug for Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drug for Ulcerative Colitis Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drug for Ulcerative Colitis Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drug for Ulcerative Colitis Sales Market Share by Region (2017-2028)
Figure 23. Global Drug for Ulcerative Colitis Revenue Market Share by Region (2017-2028)
Figure 24. North America Drug for Ulcerative Colitis Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drug for Ulcerative Colitis Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drug for Ulcerative Colitis Revenue (2017-2028) & (USD Million)
Figure 27. South America Drug for Ulcerative Colitis Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drug for Ulcerative Colitis Revenue (2017-2028) & (USD Million)
Figure 29. Global Drug for Ulcerative Colitis Sales Market Share by Type (2017-2028)
Figure 30. Global Drug for Ulcerative Colitis Revenue Market Share by Type (2017-2028)
Figure 31. Global Drug for Ulcerative Colitis Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 33. Global Drug for Ulcerative Colitis Revenue Market Share by Application (2017-2028)
Figure 34. Global Drug for Ulcerative Colitis Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Drug for Ulcerative Colitis Sales Market Share by Type (2017-2028)
Figure 36. North America Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 37. North America Drug for Ulcerative Colitis Sales Market Share by Country (2017-2028)
Figure 38. North America Drug for Ulcerative Colitis Revenue Market Share by Country (2017-2028)
Figure 39. United States Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drug for Ulcerative Colitis Sales Market Share by Type (2017-2028)
Figure 43. Europe Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 44. Europe Drug for Ulcerative Colitis Sales Market Share by Country (2017-2028)
Figure 45. Europe Drug for Ulcerative Colitis Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drug for Ulcerative Colitis Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drug for Ulcerative Colitis Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drug for Ulcerative Colitis Revenue Market Share by Region (2017-2028)
Figure 55. China Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drug for Ulcerative Colitis Sales Market Share by Type (2017-2028)
Figure 62. South America Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 63. South America Drug for Ulcerative Colitis Sales Market Share by Country (2017-2028)
Figure 64. South America Drug for Ulcerative Colitis Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drug for Ulcerative Colitis Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drug for Ulcerative Colitis Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drug for Ulcerative Colitis Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drug for Ulcerative Colitis Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drug for Ulcerative Colitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drug for Ulcerative Colitis in 2021
Figure 76. Manufacturing Process Analysis of Drug for Ulcerative Colitis
Figure 77. Drug for Ulcerative Colitis Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source